Berry Genomics Co (SZSE:000710) COGS-to-Revenue : 0.51 (As of Mar. 2025)

View and export this data going back to 1997. Start your Free Trial

What is Berry Genomics Co COGS-to-Revenue?

Berry Genomics Co's Cost of Goods Sold for the three months ended in Mar. 2025 was ¥110 Mil. Its Revenue for the three months ended in Mar. 2025 was ¥218 Mil.

Berry Genomics Co's COGS to Revenue for the three months ended in Mar. 2025 was 0.51.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Berry Genomics Co's Gross Margin % for the three months ended in Mar. 2025 was 49.48%.

Berry Genomics Co COGS-to-Revenue Historical Data

The historical data trend for Berry Genomics Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Berry Genomics Co COGS-to-Revenue Chart

Berry Genomics Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

COGS-to-Revenue

Get a 7-Day Free Trial

0.47

0.55

0.57

0.55

0.53

Berry Genomics Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
COGS-to-Revenue	Get a 7-Day Free Trial															0.45	0.51	0.53	0.65	0.51

Berry Genomics Co COGS-to-Revenue Calculation

Berry Genomics Co's COGS to Revenue for the fiscal year that ended in Dec. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	572.909	/	1078.165
	=	0.53

Berry Genomics Co's COGS to Revenue for the quarter that ended in Mar. 2025 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	110.008	/	217.759
	=	0.51

Berry Genomics Co (SZSE:000710) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Berry Genomics Co's Gross Margin % for the three months ended in Mar. 2025 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	110.008 / 217.759
	=	49.48 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Berry Genomics Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Berry Genomics Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Berry Genomics Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Berry Genomics Co Ltd (SZSE:000710) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

Life Park Road, Building 5, Courtyard 4, Science and Technology Park, Changping District, Beijing, CHN

Website

http://www.berrygenomics.com

Berry Genomics Co Ltd is a biotechnology company. It providess gene sequencing detection equipment and services.

Executives

Gao Yang	Directors, executives
Hou Ying	Directors, executives
Wang Yu Jing	Supervisors
Wang Dong	Directors, executives
Zhou Dai Xing	Directors, executives
Ou Yang Xiang Yu	Supervisors
Li Guang Chao	Independent director
Gu Zhong Guo	Directors, executives
Wen Wu	Director
Ding Xian Xing	Supervisors

Berry Genomics Co Headlines

No Headlines